Hiroomi Tada

2021

In 2021, Hiroomi Tada earned a total compensation of $2.5M as Chief Medical Officer at Tyra Biosciences.

Compensation breakdown

Non-Equity Incentive Plan$114,735
Option Awards$1,991,713
Salary$403,778
Other$1,135
Total$2,511,361

Tada received $2M in option awards, accounting for 79% of the total pay in 2021.

Tada also received $114.7K in non-equity incentive plan, $403.8K in salary and $1.1K in other compensation.

Rankings

In 2021, Hiroomi Tada's compensation ranked 5,134th out of 12,415 executives tracked by ExecPay. In other words, Tada earned more than 58.6% of executives.

ClassificationRankingPercentile
All
5,134
out of 12,415
59th
Division
Manufacturing
2,161
out of 5,505
61st
Major group
Chemicals And Allied Products
930
out of 2,375
61st
Industry group
Drugs
831
out of 2,096
60th
Industry
Pharmaceutical Preparations
595
out of 1,546
62nd
Source: SEC filing on April 28, 2022.

Tada's colleagues

We found three more compensation records of executives who worked with Hiroomi Tada at Tyra Biosciences in 2021.

2021

Todd Harris

Tyra Biosciences

Chief Executive Officer

2021

Ronald Swanson

Tyra Biosciences

Chief Scientific Officer

2021

Daniel Bensen

Tyra Biosciences

Chief Operating Officer

News

In-depth

You may also like